Record NNP B-NP O
date NN I-NP O
: : O O
2078-03-26 CD O B-DATE
Grace NNP B-NP B-HOSPITAL
Cottage NNP I-NP I-HOSPITAL
Surgery NNP I-NP O
Service NNP I-NP O
Consult NNP B-NP O
Note NN I-NP O
Patient NNP B-NP O
: : O O
Vaughn NNP B-NP I-PATIENT
, , O I-PATIENT
Frank NNP B-NP I-PATIENT
MRN NNP B-NP O
: : O O
6767510 CD O B-MEDICALRECORD
Date NNP B-NP O
: : O O
3/26/78 CD O B-DATE
CC NNP B-NP O
: : O O
Cellulitis NNP B-NP O
of IN B-PP O
abdominal NN B-NP O
pannus NN I-NP O
HPI NNP B-NP O
: : O O
Mr. NNP B-NP O
Vaughn NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
33 CD I-NP B-AGE
yo NNP I-NP O
diabetic NN I-NP O
male NN I-NP O
with IN B-PP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
Fournier&#8217 CD B-NP O
;s NN I-NP O
gangrene NN I-NP O
s/p NN I-NP O
multiple JJ I-NP O
debridements NNS I-NP O
and CC O O
diverting VBG B-VP O
colostomy NN B-NP O
in IN B-PP O
January NNP B-NP B-DATE
2077 CD I-NP I-DATE
who WP B-NP O
was VBD B-VP O
recently RB I-VP O
admitted VBN I-VP O
to TO B-PP O
the DT B-NP O
LH NNP I-NP B-HOSPITAL
service NN I-NP O
3/15 CD B-NP B-DATE
- : O O
3/16/78 CD B-NP B-DATE
for IN B-PP O
cellulitis NN B-NP O
of IN B-PP O
his PRP$ B-NP O
abdominal JJ I-NP O
pannus NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
discharged VBN I-VP O
on IN B-PP O
Bactrim NNP B-NP O
DS NNPS I-NP O
one CD I-NP O
tab NN I-NP O
QD NN I-NP O
but CC I-NP O
returns NNS I-NP O
today NN I-NP O
complaining VBG B-VP O
of IN B-PP O
fever NN B-NP O
to TO B-PP O
101.9 CD B-NP O
at IN B-PP O
home NN B-NP O
with IN B-PP O
chills NNS B-NP O
and CC I-NP O
nausea NN I-NP O
but CC O O
no DT B-NP O
vomiting NN I-NP O
. . O O
He PRP B-NP O
states VBZ B-VP O
that IN O O
his PRP$ B-NP O
pannus NN I-NP O
has VBZ B-VP O
become VBN I-VP O
more RBR B-ADJP O
tender JJ I-ADJP O
to TO B-VP O
touch VB I-VP O
and CC O O
in IN B-PP O
particular JJ B-NP O
, , O O
there EX B-NP O
has VBZ B-VP O
been VBN I-VP O
some DT B-NP O
swelling VBG I-NP O
of IN B-PP O
the DT B-NP O
left JJ I-NP O
side NN I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
also RB I-VP O
noted VBN I-VP O
high JJ B-NP O
blood NN I-NP O
sugars NNS I-NP O
( -LRB- O O
300s NNS B-NP O
) -RRB- B-VP O
over IN B-PP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
days NNS I-NP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
dysuria NN B-NP O
or CC O O
any DT B-NP O
change NN I-NP O
in IN B-PP O
his PRP$ B-NP O
ostomy NN I-NP O
output NN I-NP O
. . O O
PMH: NNP B-NP O
HTN NNP I-NP O
Hypercholesterolemia NNP B-NP O
DM NNP B-NP O
II NNP I-NP O
Fournier NNP B-NP O
's POS B-NP O
gangrene NN I-NP O
s/p NN I-NP O
multiple JJ I-NP O
debridements NNS I-NP O
and CC O O
diverting VBG B-VP O
colostomy NN B-NP O
1/76 . O B-DATE
PSH NNP B-NP O
: : O O
Open VB B-VP O
diverting VBG I-VP O
sigmoid JJ B-NP O
colostomy NN I-NP O
, , I-NP O
irrigation NN I-NP O
and CC I-NP O
debridement NN I-NP O
of IN B-PP O
perineum NN B-NP O
2/6/77 CD I-NP B-DATE
Multiple JJ B-NP O
debridements NNS I-NP O
and CC O O
EUA NNS B-NP O
's POS B-NP O
related VBN I-NP O
to TO B-PP O
Fournier NNP B-NP O
's POS B-NP O
gangrene NN I-NP O
Medications NNS B-NP O
: : O O
Insulin NNP B-NP O
Glargine NNP I-NP O
( -LRB- I-NP O
Lantus NNP I-NP O
) -RRB- I-NP O
60 CD I-NP O
U NNP I-NP O
SC NNP I-NP O
QHS . O O
Simvastatin NNP B-NP O
40 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
Metoprolol NNP B-NP O
Succinate NNP I-NP O
Extended NNP I-NP O
Release NNP I-NP O
( -LRB- I-NP O
Toprol NNP I-NP O
Xl NNP I-NP O
) -RRB- I-NP O
100 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
Nystatin NNP B-NP O
Powder NNP I-NP O
1 CD I-NP O
APPLICATION NNP I-NP O
TOP NNP I-NP O
TID NNP I-NP O
Trimethoprim/sulfamethoxazole NNP B-NP O
Double NNP I-NP O
Strength NNP I-NP O
( -LRB- I-NP O
Bactrim NN I-NP O
Ds NNS I-NP O
) -RRB- O O
1 CD B-NP O
TAB NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
Oxycodone NNP B-NP O
10 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
Q6H NNP I-NP O
prn NN I-NP O
Allergies NNP B-NP O
: : O O
HYDROCHLOROTHIAZIDE NNP B-NP O
( -LRB- I-NP O
Hyponatremia NN I-NP O
) -RRB- O O
IOPAMIDOL NNP B-NP O
76 CD I-NP O
% NN I-NP O
( -LRB- I-NP O
SOB NNP I-NP O
) -RRB- O O
IV NNP B-NP O
Contrast NNP I-NP O
( -LRB- I-NP O
rash NN I-NP O
) -RRB- O O
SH NNS B-NP O
: : O O
Tob NNP B-NP O
: : O O
denies VBZ O O
EtOH NNP B-NP O
: : O O
occasional JJ O O
Electroencephalographic NNP B-NP B-PROFESSION
Technologist NNP I-NP I-PROFESSION
, , O O
lives VBZ B-VP O
w/ RB B-ADVP O
mother NN B-NP O
PE NN B-NP O
: : O O
T NNP B-NP O
95.7 CD I-NP O
, , O O
P NNP B-NP O
83 CD I-NP O
, , I-NP O
186/100 CD I-NP O
, , O O
RR NNP B-NP O
18 CD I-NP O
, , I-NP O
100 CD I-NP O
% NN I-NP O
on IN B-PP O
RA NNP B-NP O
Gen NNP B-NP O
: : O O
Obese NNP B-NP O
male NN I-NP O
in IN B-PP O
NAD NNP B-NP O
CV NNP B-NP O
: : O O
RRR NN B-NP O
Pulm NNP B-NP O
: : O O
CTAB NN B-NP O
Abd NNP B-NP O
: : O O
Obese NN B-NP O
, , O O
large JJ B-NP O
pannus NN I-NP O
with IN B-PP O
macerated JJ B-NP O
skin NN I-NP O
in IN B-PP O
folds NNS B-NP O
. . B-NP O
Area NN I-NP O
of IN B-PP O
induration NN B-NP O
, , O O
erythema NN B-NP O
, , O O
and CC O O
tenderness NN B-NP O
on IN B-PP O
left JJ B-NP O
side NN I-NP O
, , I-NP O
small JJ I-NP O
area NN I-NP O
of IN B-PP O
fluctuance NN B-NP O
, , O O
pannus RB B-ADVP O
warm JJ B-ADJP O
to TO B-VP O
touch VB I-VP O
. . O O
Abdomen NNP O O
otherwise RB B-ADJP O
soft JJ I-ADJP O
, , O O
non-tender JJ B-ADJP O
to TO B-PP O
palpation NN B-NP O
. . O O
Labs NNS B-NP O
on IN B-PP O
admission NN B-NP O
: : O O
Test NNP B-NP O
Description NNP I-NP O
Result NNP I-NP O
Flags NNP I-NP O
Ref NNP I-NP O
. . I-NP O
Range NNP I-NP O
Units . O O
WBC NNP B-NP O
9.0 CD I-NP O
( -LRB- I-NP O
4.5-11.0) JJ I-NP O
th/cmm NN I-NP O
HCT NNP B-NP O
35.5 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
41.0-53.0) CD I-NP O
% NN I-NP O
HGB NNP B-NP O
13.3 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
13.5-17.5 CD I-NP O
) -RRB- I-NP O
gm/dl . O O
RBC NNP B-NP O
4.39 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
4.50-5.90 CD I-NP O
) -RRB- I-NP O
mil/cmm . O O
PLT NNP B-NP O
299 CD I-NP O
( -LRB- I-NP O
150-400 CD I-NP O
) -RRB- I-NP O
th/cumm . O O
MCV NN B-NP O
81 CD I-NP O
( -LRB- I-NP O
80-100 CD B-PP O
) -RRB- B-NP O
fl NN I-NP O
MCH NNP B-NP O
30.4 CD I-NP O
( -LRB- I-NP O
26.0-34.0) JJ I-NP O
pg/rbc NN I-NP O
MCHC NNP B-NP O
37.5 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
31.0-37.0) JJ I-NP O
g/dl NN I-NP O
RDW RB B-NP O
14.6 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
11.5-14.5 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Superstat NNP B-NP O
PT NNP I-NP O
12.2 CD I-NP O
( -LRB- I-NP O
10.3-13.2 CD B-PP O
) -RRB- B-NP O
sec NN I-NP O
Icteric JJ O O
Superstat NNP B-NP O
PT-INR NNP I-NP O
1.1 CD O O
Icteric JJ O O
DIFFERENTIAL NNP B-NP O
REQUEST NNP I-NP O
RECEIVED NNP I-NP O
Diff JJ B-NP O
Method NNP I-NP O
See VB I-NP O
Result NN I-NP O
Below IN B-PP O
Result NN B-NP O
: : O O
Automated VBN B-VP O
with IN B-PP O
manual JJ B-NP O
review NN I-NP O
Poly NNP B-NP O
79 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
40-70 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Lymphs NNP B-NP O
16 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
22-44 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
Monos NNP B-NP O
4 CD I-NP O
( -LRB- I-NP O
4-11 JJ I-NP O
) -RRB- I-NP O
% NN I-NP O
EOS NNS B-NP O
1 CD B-NP O
(0-8 CD I-NP O
) -RRB- O O
% NN O O
Basos NNS B-NP O
0 CD B-NP O
(0-3 JJ I-NP O
) -RRB- I-NP O
% NN I-NP O
Plasma NNP B-NP O
Sodium NNP I-NP O
131 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
135-145 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Potassium NNP I-NP O
3.9 CD I-NP O
( -LRB- I-NP O
3.4-4.8 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
SLIGHTLY NNP B-NP O
HEMOLYZED NNP I-NP O
Plasma NNP B-NP O
Chloride NNP I-NP O
95 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
100-108 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Carbon NNP I-NP O
Dioxide NNP I-NP O
22.0 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
23.0-31.9 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Anion NNP I-NP O
GAP NNP I-NP O
14 CD I-NP O
(3-15 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Plasma NNP B-NP O
Urea NNP I-NP O
Nitrogen NNP I-NP O
9 CD I-NP O
(8-25 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Plasma NNP B-NP O
Creatinine NNP I-NP O
0.74 CD I-NP O
( -LRB- I-NP O
0.60-1.50 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
eGFR NN B-NP O
&gt IN B-PP O
;60 CD B-NP O
mL/min/1.73m2 . O O
Plasma NNP B-NP O
Glucose NNP I-NP O
236 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
70-110 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Calcium NNP B-NP O
9.2 CD I-NP O
( -LRB- I-NP O
8.5-10.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Phosphorus NNP B-NP O
2.8 CD I-NP O
( -LRB- I-NP O
2.6-4.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Magnesium NNP B-NP O
1.5 CD I-NP O
( -LRB- O O
1.4-2.0) CD B-NP O
meq/L NN I-NP O
Total JJ B-NP O
Protein NNP I-NP O
6.8 CD I-NP O
( -LRB- I-NP O
6.0-8.3 NN I-NP O
) -RRB- I-NP O
g/dl . O O
Albumin NNP B-NP O
3.8 CD I-NP O
( -LRB- I-NP O
3.3-5.0) NN I-NP O
g/dl NN I-NP O
Globulin NNP B-NP O
3.0 CD I-NP O
( -LRB- I-NP O
2.6-4.1 CD I-NP O
) -RRB- I-NP O
g/dl . O O
Direct JJ B-NP O
Bilirubin NNP I-NP O
0.1 CD I-NP O
(0-0.4 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Total JJ B-NP O
Bilirubin NNP I-NP O
0.5 CD I-NP O
( -LRB- B-VP O
0.0-1.0) CD B-NP O
mg/dl NN I-NP O
Alkaline NNP B-NP O
Phosphatase NNP I-NP O
100 CD I-NP O
( -LRB- I-NP O
45-115 CD I-NP O
) -RRB- I-NP O
U/L . O O
Transaminase-SGPT NN B-NP O
32 CD I-NP O
( -LRB- O O
10-55 CD B-NP O
) -RRB- I-NP O
U/L . O O
Transaminase-SGOT JJ B-NP O
21 CD I-NP O
( -LRB- B-NP O
10-40 CD I-NP O
) -RRB- I-NP O
U/L . O O
Plasma NNP B-NP O
Lactic NNP I-NP O
Acid NNP I-NP O
2.5 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
0.5-2.2 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Micro NNP B-NP O
: : O O
Blood NN B-NP O
culture NN I-NP O
pending VBG B-LST O
Urine JJ B-NP O
culture NN I-NP O
pending VBG I-NP O
Abdominal JJ B-NP O
wound NN I-NP O
cx NN I-NP O
pending VBG I-NP O
Studies NNS B-NP O
: : O O
CXR NNP B-NP O
: : O O
Lung NNP B-NP O
fields VBZ B-VP O
clear JJ B-ADJP O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
pneumonia NN B-NP O
. . O O
CT NNP B-NP O
abd/pelvis:There NN I-NP O
is VBZ B-VP O
mild JJ B-NP O
inflammatory JJ I-NP O
fat JJ I-NP O
stranding NN I-NP O
, , O O
heterogeneity NN B-NP O
, , O O
and CC O O
slightly RB B-ADVP O
increased VBN B-VP O
vascularity NN B-NP O
involving VBG B-VP O
the DT B-NP O
anterior JJ I-NP O
abdominal JJ I-NP O
wall NN I-NP O
, , O O
extending VBG B-VP O
in IN B-PP O
to TO B-PP O
the DT B-NP O
scrotum NN I-NP O
without IN B-PP O
evidence NN B-NP O
of IN B-PP O
drainable JJ B-NP O
fluid NN I-NP O
collection NN I-NP O
or CC I-NP O
air NN I-NP O
pockets NNS I-NP O
. . O O
Mild NNP B-NP O
induration NN I-NP O
and CC I-NP O
thickening NN I-NP O
of IN B-PP O
the DT B-NP O
overlying VBG I-NP O
skin NN I-NP O
of IN B-PP O
the DT B-NP O
abdominal JJ I-NP O
wall NN I-NP O
is VBZ B-VP O
also RB I-VP O
noted VBN I-VP O
. . B-NP O
Stable NNP I-NP O
postsurgical JJ I-NP O
scar NN I-NP O
in IN B-PP O
the DT B-NP O
right JJ I-NP O
anterior JJ I-NP O
abdominal JJ I-NP O
wall NN I-NP O
. . O O
Surgical JJ B-NP O
sutures NNS I-NP O
in IN B-PP O
the DT B-NP O
anterior JJ I-NP O
abdominal JJ I-NP O
wall NN I-NP O
. . O O
There EX B-NP O
is VBZ B-VP O
a DT B-NP O
superficial JJ I-NP O
soft JJ I-NP O
tissue NN I-NP O
mass NN I-NP O
in IN B-PP O
the DT B-NP O
subcutaneous JJ I-NP O
tissue NN I-NP O
of IN B-PP O
the DT B-NP O
left JJ I-NP O
anterior JJ I-NP O
abdominal JJ I-NP O
wall NN I-NP O
, , O O
slightly RB B-ADVP O
larger JJR I-ADVP O
on IN B-PP O
the DT B-NP O
current JJ I-NP O
study NN I-NP O
measuring VBG B-VP O
approximately RB B-NP O
3.3 CD I-NP O
cm NN I-NP O
. . O O
There EX B-NP O
are VBP B-VP O
mild JJ B-NP O
degenerative JJ I-NP O
changes NNS I-NP O
involving VBG B-VP O
the DT B-NP O
thoracic NN I-NP O
and CC I-NP O
lumbar NN I-NP O
spine NN I-NP O
. . O O
Procedure NNP B-NP O
note NN I-NP O
: : O O
The DT B-NP O
area NN I-NP O
of IN B-PP O
induration NN B-NP O
on IN B-PP O
the DT B-NP O
left JJ I-NP O
side NN I-NP O
of IN B-PP O
the DT B-NP O
patient&#8217 NN I-NP O
;s NN I-NP O
pannus NN I-NP O
was VBD B-VP O
prepped VBN I-VP O
with IN B-PP O
betadine NN B-NP O
. . O O
5cc '' O O
of IN B-PP O
1 CD B-NP O
% NN I-NP O
lidocaine NN I-NP O
without IN B-PP O
epinephrine NN B-NP O
was VBD B-VP O
infiltrated VBN I-VP O
into IN B-PP O
the DT B-NP O
area NN I-NP O
. . O O
A DT B-NP O
2cm JJ I-NP O
incision NN I-NP O
was VBD B-VP O
made VBN I-VP O
over IN B-PP O
the DT B-NP O
area NN I-NP O
of IN B-PP O
fluctuance NN B-NP O
and CC O O
approximately RB B-NP O
8cc JJ I-NP O
of IN B-PP O
purulent JJ B-NP O
thick JJ I-NP O
fluid NN I-NP O
was VBD B-VP O
expressed VBN I-VP O
. . O O
A DT B-NP O
culture NN I-NP O
of IN B-PP O
the DT B-NP O
abscess NN I-NP O
fluid NN I-NP O
was VBD B-VP O
sent VBN I-VP O
. . O O
The DT B-NP O
wound NN I-NP O
was VBD B-VP O
probed VBN I-VP O
gently RB B-ADVP O
to TO B-VP O
break VB I-VP O
up RP B-PRT O
any DT B-NP O
loculations NNS I-NP O
. . O O
The DT B-NP O
wound NN I-NP O
was VBD B-VP O
then RB I-VP O
packed VBN I-VP O
with IN B-PP O
&# JJ B-NP O
188 CD I-NP O
; : O O
inch NN B-NP O
dry JJ I-NP O
packing NN I-NP O
tape NN I-NP O
. . O O
A DT B-NP O
dry JJ I-NP O
sterile JJ I-NP O
dressing NN I-NP O
was VBD B-VP O
applied VBN I-VP O
. . O O
The DT B-NP O
patient NN I-NP O
tolerated VBD B-VP O
the DT B-NP O
procedure NN I-NP O
well RB B-ADVP O
. . O O
Impression/Plan NN B-NP O
: : O O
33 CD B-NP B-AGE
year NN I-NP O
old JJ I-NP O
diabetic NN I-NP O
male NN I-NP O
with IN B-PP O
history NN B-NP O
of IN B-PP O
Fournier&#8217 CD B-NP O
;s NNS I-NP O
gangrene JJ B-NP O
s/p NN I-NP O
multiple JJ I-NP O
debridements NNS I-NP O
and CC O O
diverting VBG B-VP O
colostomy NN B-NP O
presents NNS I-NP O
with IN B-PP O
recurrent JJ B-NP O
cellulitis NN I-NP O
and CC I-NP O
abscess NN I-NP O
of IN B-PP O
the DT B-NP O
left JJ I-NP O
side NN I-NP O
of IN B-PP O
his PRP$ B-NP O
pannus NN I-NP O
. . O O
The DT B-NP O
abscess NN I-NP O
was VBD B-VP O
drained VBN I-VP O
and CC I-VP O
packed VBN I-VP O
in IN B-PP O
the DT B-NP O
ED. NNP I-NP O
The DT B-NP O
patient NN I-NP O
will MD B-VP O
be VB I-VP O
admitted VBN I-VP O
for IN B-PP O
IV NNP B-NP O
antibiotics NNS I-NP O
and CC O O
careful JJ B-NP O
monitoring NN I-NP O
of IN B-PP O
his PRP$ B-NP O
cellulitis NN I-NP O
. . O O
- : O O
Admit NN B-NP O
to TO B-PP O
Langmack NNP B-NP B-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
Surgery NNP I-NP O
, , O O
Senior NNP B-NP O
Resident NNP I-NP O
: : O O
Dr. NNP B-NP O
Imani NNP I-NP B-DOCTOR
Blevins NNPS O I-DOCTOR
- : O O
BID NN B-NP O
wound NN I-NP O
packing VBG B-LST O
- : O O
Linezolid/Cefepime/Flagyl NN B-NP O
( -LRB- B-NP O
prior RB I-NP O
abscess JJ I-NP O
cultures NNS I-NP O
: : O O
pseudomonas NNS B-NP O
sensitive JJ B-ADJP O
to TO B-VP O
linezolid VB I-VP O
, , O O
klebsiella NN B-NP O
sensitive JJ B-ADJP O
to TO B-PP O
cefepime NN B-NP O
) -RRB- O O
- : O O
Follow VB B-VP O
up RP B-PRT O
wound NN B-NP O
culture NN I-NP O
- : O O
Serial JJ B-NP O
exams NNS I-NP O
with IN B-PP O
careful JJ B-NP O
monitoring NN I-NP O
for IN B-PP O
spread NN B-NP O
of IN B-PP O
cellulitis NN B-NP O
. . O O
Patient NNP B-NP O
discussed VBD B-VP O
with IN B-PP O
Dr. NNP B-NP O
Wesley NNP I-NP B-DOCTOR
Nieves NNP I-NP I-DOCTOR
, , O O
LH NNP B-NP B-HOSPITAL
Surgical NNP I-NP O
Senior NNP I-NP O
. . O O
Susan NNP B-NP B-DOCTOR
Noyes NNP I-NP I-DOCTOR
, , O O
MD . O O
ED VBN B-VP O
Surgical NNP B-NP O
Senior NNP I-NP O
P NNP B-NP O
26381 CD I-NP B-PHONE
